Indice del forum


psp-film megaupload

PortalPortale  blogBlog  AlbumAlbum  Gruppi utentiGruppi utenti  Lista degli utentiLista degli utenti  GBGuestbook  Pannello UtentePannello Utente  RegistratiRegistrati 
 FlashChatFlashChat  FAQFAQ  CercaCerca  Messaggi PrivatiMessaggi Privati  StatisticheStatistiche  LinksLinks  LoginLogin 
 CalendarioCalendario  DownloadsDownloads  Commenti karmaCommenti karma  TopListTopList  Topics recentiTopics recenti  Vota ForumVota Forum

Sales of Spinal Muscular Atrophy Market to Cross
Utenti che stanno guardando questo topic:0 Registrati,0 Nascosti e 0 Ospiti
Utenti registrati: Nessuno

Nuovo Topic   Rispondi    Indice del forum -> Forum di prova
PrecedenteInvia Email a un amico.Utenti che hanno visualizzato questo argomentoSalva questo topic come file txtVersione stampabileMessaggi PrivatiSuccessivo
Autore Messaggio



Registrato: 29/06/19 08:12
Messaggi: 277
earasryhqaey is offline 

MessaggioInviato: 12 Feb 2020 11:02:32    Oggetto:  Sales of Spinal Muscular Atrophy Market to Cross
Rispondi citando

Sales of Spinal Muscular Atrophy Market to Cross US$0.47 globally by the end of 2023   , reports TMR Health Articles | August 16, 2016

Spinal muscular atrophy (SMA) is a hereditary autosomal recessive disease affecting areas of the nervous system that control voluntary muscle movement. Mutation in survival motor neuron (SMN) gene causes deficiency of SMN protein.

A new report, titled “Spinal Muscular Atrophy Market - Pipeline Assessment, Size, Growth, Trends   , and Forecast 2015 - 2023” has been published by Transparency Market Research. The study offers a detailed analysis of the聽spinal muscular atrophy market, providing insights into the pipeline assessment, major growth drivers, restraints, and potential opportunities. According to the research study, the spinal muscular atrophy phase three candidate ISIS-SMNRx is projected to generate revenue of US$0.47 by the end of 2023 in the U.S.聽

Request a Free Research Sample:

Spinal muscular atrophy is genetic neuromuscular disease that is characterized by muscle weakness and atrophy. This disease is the leading genetic cause of death in toddlers and infants   , given that it generally manifests early in life. According to the Spinal Muscular Atrophy Association, this disease affects an estimated 10,000 to 25,000 adults and children in the U.S. alone, making it one of the most common rare diseases. The association reveals that an estimated 6 million Americans are carriers of the SMA gene and one in 6,000 to one in 10   ,000 kids are born with this neuromuscular disease.

The research report offers key insights into the prevalence and current treatment pattern of spinal muscular atrophy, identifying major market drivers, opportunities, and restraints in the global market for spinal muscular atrophy therapeutics. An analysis of market attractiveness with respect to geography takes into consideration several factors such as **** pricing policies, current competition intensity, patient population   , regulatory restrictions, and present state of the healthcare sector. This gives readers a clear picture of the potential of each geographical segment of the spinal muscular atrophy market.

The spinal muscular atrophy therapeutics market is segmented into early stage candidates and late stage candidates. Early stage candidates of Phase 1 and Phase 2 include LMI070, CK-2127107, RG3039, Olesoxime (TRO19622), RO6885247   , and . Late stage candidates of Phase 3 include ISIS-SMN Rx. This Phase 3 candidate for the treatment of Type 1 and Type 2 SMA is present an annual sales of US$0.4 bn in the US by the end of the forecast period in 2023.

Europe and the US are presently the dominating markets for spinal muscular atrophy therapeutics owing to the fact that these regions have a greater percentage of diagnosed cases of SMA. Private and government organizations have been largely involved in creating awareness about spinal muscular atrophy. In addition, the governments in these regions have been offering incentives for the development of therapeutic options for the treatment of rare diseases, which in turn boosts research and development in the field of spinal muscular atrophy.

The major companies competing in this space are F. Hoffmann-La Roche Ltd., Isis Pharmaceuticals, Inc., AveXis   , Inc., Cytokinetics, Inc., and Novartis AG, and these players have been profiled in the report with the help of several market intelligence tools. Their strengths, weaknesses   , opportunities, and threats have been evaluated, along with a detailed assessment of their product offerings.

From Nothing to Homeopathy Online now

Being an area of medicine which was not very popular until the 21st century, the current presence of homeopathy online is being a hit already. In the world of medicine, the western treatment has already established its name decades back. But as it is said, better late than never   , homeopathy started gathering back its popularity later with the various alternative ways of its treatment methodology.

Difficulty in pointing out the Best Homeopathic Doctor

Since this field of medicine is still on the process of regaining awareness about it among the population of the world, it is not very easy to identify the best homeopathic doctor in town. People might have to travel long distances in search for one. Even if they do find the best doctor in the field of homeopathic medicine, they might have to wait in long queues as well until they are called out for their turn to consult the doctor.

Online Homeopathic Consultation is a boon

The world of today has developed so much that most of the needs of the people on this planet are getting identified in such a way so as to make available every product and service they wish for from the World Wide Web itself. Similarly, in the click of a button, online homeopathic consultation could also be obtained making life easier for those trying to get treatment only from this medicinal area.

The doctors are made available in the online forums handling such issues at any hour of the day. That means they are available 24x7. If the person trying to get a consultation online is doing it for the first time, then he also benefits from a free consultation as well as the first time interactions with the doctor are totally free of cost.

The World of Online Homeopathic Treatment

Mobile phone applications and websites have been created to pay a visit to any doctor in homeopathy online without the hassles of waiting in very long queues or traveling long distances to meet the doctor. Such ways of being able to get online homeopathic treatment has been proven beneficial for people all over the world majorly in regard to the above mentioned challenges.

Many a t.                    
Torna in cima
Profilo Messaggio privato

MessaggioInviato: 12 Feb 2020 11:02:32    Oggetto: Adv

Torna in cima
Mostra prima i messaggi di:   
Nuovo Topic   Rispondi    Indice del forum -> Forum di prova Tutti i fusi orari sono GMT + 1 ora
Pagina 1 di 1

Vai a:  
Non puoi inserire nuovi Topic in questo forum
Non puoi rispondere ai Topic in questo forum
Non puoi modificare i tuoi messaggi in questo forum
Non puoi cancellare i tuoi messaggi in questo forum
Non puoi votare nei sondaggi in questo forum
Non puoi allegare files in questo forum
Non puoi downloadare files da questo forum

psp-film topic RSS feed 
Powered by with phpBB © 2003 - 2008